Videos

GYN oncologist Dr. Ami Vaidya, explains what gynecologic cancers are, why awareness matters and how patients can learn to recognize symptoms.

An incoming medical oncologist at the University of Cincinnati on how patient values shape treatment, and what precision medicine can now target.

Dr. Matthew Karr explains how CAR T-cell therapy works, who may be eligible and how doctors decide when to treat or monitor cancer.

A medical oncologist at UC San Diego Health on choosing between surgery and radiation, and why precision oncology changes what patients should ask first.

Nicole Echols discusses Lung Cancer Initiative, reducing lung cancer stigma, biomarker testing, early detection and support for patients and caregivers.

Dr. Jia Luo explains how chemotherapy, targeted therapy and immunotherapy work for lung cancer, plus tips for managing treatment side effects.

Long-term survivorship in small cell lung cancer was not expected 20 years ago. A radiation oncologist explains what that shift means for patients today.

Cancer drugs sit in a protected class under Medicare Part D, but plans can still deny coverage. A researcher from Vanderbilt found that many of those denials do not hold up under outside review.

Andrew Evens, DO & Joanna Rhodes, MD on CLL's transformation, CAR-T vs bispecifics, Hodgkin survivorship, and delivering world-class lymphoma care across New Jersey.

Cat-camel exercises can gently improve spine mobility and comfort. Learn how this simple movement can support flexibility during cancer recovery.

Juanita Segura shares her nearly 12-year lung cancer journey, the power of community and why she advocates for biomarker testing and hope.

Learn what lung cancer stages mean, why biomarker testing matters, and how advances in precision medicine are changing treatment for patients.

Leslie Waltke demonstrates gentle trunk rotations to help improve mobility in the lower and upper spine. Learn how to safely perform this exercise at home.

Cara Curcio’s melanoma journey changed her life as a wife and mother, but treatment, family and hope have kept her moving forward.

Nicole Schultz was treated for acute myeloid leukemia as a teenager. Two decades later, chronic graft-versus-host disease and ongoing survivorship monitoring remain part of her care.

A multiple myeloma survivor and advocate answers the questions people ask most after a diagnosis, from maintenance therapy to stem cell transplant.

Dr. Priscilla Merriam discusses how sarcomas can be mistaken for benign growths like lipomas and fibroids, and why asking about a biopsy can matter before surgery.

Lung cancer advocate Katie shares how losing her father to the disease and her own cancer journey inspire her work with LiveLung today.

An oncologist explains why the choice between removing one lobe or the whole thyroid should be a conversation, not a surprise.

An incidental CT scan revealed stage 1A lung cancer. After robotic surgery at Hackensack University Medical Center, Carolyn Rothfeld describes a recovery that took longer than she expected.

Diagnosed with stage 1 lung cancer at 40, Gillian Ryan shares the overwhelming guilt she felt about bringing cancer into her family’s life.

Diagnosed with limited-stage small-cell lung cancer, Tammy shares how treatment progress and a mindset shift helped her find hope.

Dr. Ajay Nooka discusses the MonumenTAL-6 trial and explains what the promising Tecvayli plus Talvey results could mean for patients with relapsed multiple myeloma.

Heather Prather shares her stage 4 non small cell lung cancer journey, finding hope, joy and support through the LiveLung community and cancer advocacy.

A simple balance exercise for cancer patients: the Drinking Bird. Learn how this single-leg move builds stability, strength, and confidence safely.

Serene Hesri was 25 when Hodgkin lymphoma was diagnosed. After relapsing, she enrolled in a clinical trial — and has been in remission for five years.

Kristie Kahl of CURE spoke with Nicole Wright Dirks, a volunteer with Blue Faery, a patient advocacy organization focused on liver cancer.

When Lisa Spain started Rexana's Foundation in 2006 after losing her closest friend to lung cancer just 60 days after diagnosis, the treatment landscape looked dramatically different than it does today.

Dr. Paul Oberstein discusses RASolute 302, a pancreatic cancer trial, and what a potential KRAS inhibitor breakthrough could mean for patients.

Dr. Mark Zhao of UCSF Health discusses how TAMIS and single-port robotic surgery give select rectal cancer patients less invasive care and faster recovery.